Sign in

You're signed outSign in or to get full access.

Joanne Medero

About Joanne T. Medero

Independent Board Member of the Nuveen funds’ unitary board since 2021; Class III term runs through the 2027 annual shareholder meeting. Born in 1954, she brings 30+ years of financial services and public policy experience, including senior roles at BlackRock, Barclays, and the U.S. CFTC. She holds a B.A. from St. Lawrence University (1975) and a J.D. from George Washington University Law School (1978), and oversees 220 portfolios in the fund complex.

Past Roles

OrganizationRoleTenureCommittees/Impact
BlackRock, Inc.Managing Director, Government Relations & Public Policy; Senior Advisor to Vice ChairmanMD: Dec 2009–Jul 2020; Senior Advisor: Jul 2018–Jul 2020Focused on public policy and corporate governance issues.
Barclays Group (IBIM)Managing Director, Global Head of Government Relations & Public Policy2006–2009Directed legislative and regulatory advocacy for investment banking, investment management, wealth businesses.
Barclays Global Investors (BGI)Managing Director; Global General Counsel and Corporate SecretaryJoined 1996; GC/CS until 2006Led global legal and governance functions; BGI later merged with BlackRock (2009).
Orrick, Herrington & Sutcliffe LLPPartner1993–1995Specialized in derivatives and financial markets regulation.
Commodity Futures Trading Commission (CFTC)General Counsel1989–1993Chief legal officer of U.S. derivatives regulator.
The White House (Office of Presidential Personnel)Deputy Associate Director/Associate Director for Legal and Financial Affairs1986–1989Senior legal/financial policy role.

External Roles

OrganizationRoleTenureNotes
Baltic-American Freedom FoundationBoard MemberSince 2019Non-profit focused on Baltic state educational/professional exchanges.
SIFMA Asset Management GroupChair, Steering Committee2016–2018Industry leadership in asset management policy.
Managed Funds AssociationChair, CTA/CPO & Futures Committee2010–2012Derivatives/managed futures policy leadership.
CFTC Global Markets Advisory CommitteeMember2006–2010Market structure and global derivatives policy input.

Board Governance

  • Independence: Serves as an Independent Board Member; committees she serves on are composed entirely of Independent Board Members per NYSE/NASDAQ standards.
  • Committee memberships (no chair roles disclosed for Medero):
    • Compliance, Risk Management & Regulatory Oversight Committee – Member.
    • Nominating & Governance Committee – Member.
    • Investment Committee – Member (committee co-chairs are Boateng and Lancellotta).
    • Not on Audit Committee (members listed do not include Medero).
    • Not on Closed-End Fund Committee (members listed do not include Medero).
  • Attendance: Each Board Member attended ≥75% of Board and applicable committee meetings in the last fiscal year.
  • Board structure: Unitary board overseeing 220 portfolios for governance efficiency and consistency across the complex.

Fixed Compensation

ComponentAmount (Pre-2025)Amount (Effective Jan 1, 2025)Notes
Annual retainer (Independent Board Member)$350,000$350,000Base cash retainer.
Audit Committee – membership$30,000$35,000Not applicable to Medero (not a member).
Compliance Committee – membership$30,000$35,000Medero is a member.
Investment Committee – membership$20,000$30,000Medero is a member.
Nominating & Governance – membership$20,000$25,000Medero is a member.
Closed-End Funds – membership$20,000$25,000Not applicable to Medero (not a member).
Ad hoc meeting fees$1,000–$2,500$1,000–$2,500Based on meeting length/immediacy.
Special assignment committeesChair: ≥$1,250/qtr; Member: ≥$5,000/qtrChair: ≥$1,250/qtr; Member: ≥$5,000/qtrAs assigned.
MeasureAmountPeriod/Source
Total compensation from Nuveen Funds (aggregate for last fiscal year) – Medero$461,987DEF 14A (aggregate across funds; includes deferred fees where applicable).

Additional notes:

  • No retirement/pension plans for Board Members.
  • Deferred Compensation Plan available; directors may defer fees into book accounts tracking selected Nuveen funds.

Performance Compensation

ElementStatusDetails
Annual/long-term performance bonusNot disclosed/Not applicable for directorsDirector pay is retainer + committee/meeting fees; no performance metrics disclosed.
Equity awards (RSUs/PSUs)None disclosedNo stock awards or option grants to directors disclosed.
OptionsNone disclosedNo option awards disclosed for directors.
Deferred compensationAvailableDirectors can elect to defer some/all fees; credited to a book account tracking eligible Nuveen funds; paid lump sum or over 2–20 years.
Clawback/COC/severanceNot disclosed for directorsNo such provisions disclosed for directors in the proxy.

Other Directorships & Interlocks

TypeCompany/OrganizationRoleNotes
Public company boardsNone disclosedProxy lists BAFF (non-profit) as “Other Directorships”; no public boards for Medero disclosed.
Non-profit/academicBaltic-American Freedom FoundationDirectorSince 2019.
Industry associationsSIFMA AMG; MFA; CFTC GMACChair/member rolesSee External Roles; industry policy leadership.
Related-party/affiliate tiesNone disclosed for MederoProxy table of affiliate-advised company holdings shows entries for another director (Kenny), not Medero.

Expertise & Qualifications

  • Regulatory/legal and governance expertise: Former CFTC General Counsel; partner in derivatives regulation; senior public policy roles at BlackRock and Barclays.
  • Financial industry leadership: Chaired SIFMA AMG Steering Committee and MFA CTA/CPO & Futures Committee; service on CFTC Global Markets Advisory Committee.
  • Governance fit: Independent, with experience aligning board structures and overseeing large multi-fund complexes.

Equity Ownership

Fund (subset shown includes NAC)Shares Beneficially Owned (as of Oct 22, 2025)Dollar Range in FundNotes
Nuveen California Quality Municipal Income Fund (NAC)0$0Specific to NAC (“California Quality”).
Arizona Quality0$0
California AMT-Free0$0
California Value0$0
Massachusetts Quality0$0
Aggregate across all Nuveen funds overseenOver $100,000Dollar range top-coded; exact amount not disclosed.

Board ownership guideline:

  • Governance principle: Each Board Member is expected to invest at least the equivalent of one year of compensation in funds within the Fund Complex (directly or on a deferred basis). Specific compliance status per director is not quantified in the proxy due to dollar-range disclosure.

Governance Assessment

  • Strengths

    • Independent director with deep regulatory, legal, and public policy credentials relevant to compliance, risk oversight, and governance—aligned with her committee assignments (Compliance; Nominating & Governance; Investment).
    • Attendance threshold satisfied (≥75%) in the last fiscal year, supporting engagement.
    • Compensation structure is cash-based, transparent, and recently adjusted (effective 2025) to reflect workload/committee responsibilities; deferred compensation available to align interests.
    • No related-party transactions disclosed for Medero in affiliate-advised private holdings table, reducing conflict risk.
  • Watch items / potential red flags

    • Fund-level alignment: She reported zero direct holdings in NAC as of Oct 22, 2025, though the board expects meaningful investment across the family; aggregate holdings are disclosed only as “Over $100,000,” which lacks granularity to assess compliance with the one-year-compensation guideline. Investors may prefer fund-specific skin-in-the-game.
    • Historical senior roles at large competitors (BlackRock/Barclays) are prior employment, not current ties; independence standards for committee service mitigate active conflict concerns. Monitor for any future interlocks/transactions.
  • Compensation reasonableness/context

    • 2025 structure increases committee retainers (e.g., Compliance from $30k to $35k; Investment from $20k to $30k; Nominating & Governance from $20k to $25k) and maintains $350k base retainer, reflecting expanded oversight scope of the unified board. Medero’s aggregate complex compensation reported at $461,987 for the last fiscal year.
  • Overall view

    • Medero’s regulatory/governance profile and committee placements support board effectiveness in risk, compliance, and nomination/governance processes. The absence of NAC-specific share ownership is a perception risk for fund-level alignment; however, the board’s complex-wide ownership expectation and top-coded aggregate disclosure limit definitive conclusions on compliance.